Joseph S. Dosch, Ph.D.

Affiliations: 
2011 University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
Cell Biology
Google:
"Joseph Dosch"

Parents

Sign in to add mentor
Charles Burant grad student 2011 University of Michigan
 (Examining the role of hedgehog signaling in the pancreatic tumor microenvironment.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Dosch J, Ziemke E, Wan S, et al. (2017) Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency. Oncotarget. 8: 65090-65099
Stacer AC, Wang H, Fenner J, et al. (2015) Imaging Reporters for Proteasome Activity Identify Tumor- and Metastasis-Initiating Cells. Molecular Imaging. 14: 7290201500016
Stacer AC, Wang H, Fenner J, et al. (2015) Imaging Reporters for Proteasome Activity Identify Tumor- and Metastasis-Initiating Cells. Molecular Imaging. 14: 414-28
Cavnar SP, Rickelmann AD, Meguiar KF, et al. (2015) Modeling Selective Elimination of Quiescent Cancer Cells from Bone Marrow. Neoplasia (New York, N.Y.). 17: 625-33
Ziemke EK, Dosch JS, Maust JD, et al. (2015) Sensitivity of KRAS Mutant Colorectal Cancers to Combination Therapy that Co-Targets MEK and CDK4/6. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Dosch JS, Ziemke EK, Shettigar A, et al. (2015) Cancer stem cell marker phenotypes are reversible and functionally homogeneous in a preclinical model of pancreatic cancer. Cancer Research. 75: 4582-92
Dosch J, Ziemke E, Welling T, et al. (2015) Abstract 975: Monoclonal antibody targeting of ADAM17 is an effective treatment for metastatic colorectal cancer resulting in tumor growth control and reductions of cancer stem cells Cancer Research. 75: 975-975
Dosch JS, Ziemke EK, Shettigar A, et al. (2015) Abstract 1400: Evaluation of tumor-initiating cell populations in the KPC mouse model of pancreatic cancer Cancer Research. 75: 1400-1400
Ziemke E, Dosch J, Shettigar A, et al. (2014) Abstract 4541: Dual targeting of CDK4 and MEK as a combination treatment strategy for metastatic colorectal cancer Cancer Research. 74: 4541-4541
Nyati S, Schinske-Sebolt K, Pitchiaya S, et al. (2014) Abstract 1137: Bub1 is a key regulator of TGF-β signaling Cancer Research. 74: 1137-1137
See more...